Login / Signup
Sarah Ellinor Engell
Publication Activity (10 Years)
Years Active: 2021-2024
Publications (10 Years): 7
Top Topics
Diabetic Patients
Small Animal
Blood Glucose
Experimental Designs
Top Venues
IEEE Control. Syst. Lett.
CoRR
ACC
CDC
</>
Publications
</>
Sarah Ellinor Engell
,
Karim Davari Benam
,
Henrik Bengtsson
,
John Bagterp Jørgensen
,
Anders Lyngvi Fougner
Optimal Experimental Design for System Identification in a Bi-Hormonal Intraperitoneal Artificial Pancreas.
ECC
(2024)
Sarah Ellinor Engell
,
Henrik Bengtsson
,
Karim Davari Benam
,
Anders Lyngvi Fougner
,
John Bagterp Jørgensen
Optimal Experimental Design to Estimate Insulin Response in Type 2 Diabetes.
CCTA
(2023)
Sarah Ellinor Engell
,
Tinna Björk Aradóttir
,
Tobias K. S. Ritschel
,
Henrik Bengtsson
,
John Bagterp Jørgensen
Estimating a Personalized Basal Insulin Dose from Short-Term Closed-Loop Data in Type 2 Diabetes.
CoRR
(2022)
Sarah Ellinor Engell
,
Tinna Björk Aradóttir
,
Henrik Bengtsson
,
John Bagterp Jørgensen
Correlation in Dose-Response to Rapid- and Long-Acting Insulin for People with Type 1 Diabetes.
EMBC
(2022)
Sarah Ellinor Engell
,
Tinna Björk Aradóttir
,
Tobias K. S. Ritschel
,
Henrik Bengtsson
,
John Bagterp Jørgensen
Estimating a Personalized Basal Insulin Dose from Short-Term Closed-Loop Data in Type 2 Diabetes.
CDC
(2022)
Dinesh Krishnamoorthy
,
Dimitri Boiroux
,
Tinna Björk Aradóttir
,
Sarah Ellinor Engell
,
John Bagterp Jørgensen
A Model-Free Approach to Automatic Dose Guidance in Long Acting Insulin Treatment of Type 2 Diabetes.
IEEE Control. Syst. Lett.
5 (6) (2021)
Dinesh Krishnamoorthy
,
Dimitri Boiroux
,
Tinna Björk Aradóttir
,
Sarah Ellinor Engell
,
John Bagterp Jørgensen
A Model-free Approach to Automatic Dose Guidance in Long Acting Insulin Treatment of Type 2 Diabetes.
ACC
(2021)